ReviewArchives of medical science : AMS2013

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis.

Paweł Kawalec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.